WECOSO, INC. — Department of Defense SBIR Phase II: MDA17-T003
WECOSO, INC. — SBIR Phase II award from Department of Defense.
Phase II SBIR prototype / development signal
- Phase II is where Department of Defense funds deeper R&D after feasibility. Incumbents with Phase II history are serious competitors on adjacent topics.
- Use this award as past-performance context and to map customer organizations for STRATFI/TACFI-style transition planning.
- At $1,792,157, this is a large obligation for typical SBIR Phase sizing — worth reviewing for scope breadth and teaming opportunity.
- Topic code MDA17-T003 links this award to a solicitation family — search the same topic stem for incumbents and recompete timing.
- Amount
- $1,792,157
- Agency
- Department of Defense · Missile Defense Agency
- Program / Phase
- SBIR · Phase II
- Topic
- MDA17-T003
- Solicitation
- 17.C
- NAICS
- —
- Place of performance
- CA
- Period
- 2022-08-23 → 2024-08-22
Description
The WCS approach achieves extreme miniaturization by operating at very high frequency. During the proposed Phase II, the SSC-X Team will extend on the substantial risk reduction achieved to date to realize a flight-design cryocooler that meets all of the performance (thermodynamic, exported vibration, current ripple, etc.) and environmental (thermal vacuum, random vibration, shock, EMI) requirements to enable miniature, high performance next generation infrared imaging sensors. With the compressor development having been completed in the prior phase, the Phase II initially addresses the two remaining unknowns, thermodynamic model correlation vs. operating frequency and the regenerator physical configuration. Those final risk reduction experiments lead immediately into the final design of the flight-design SSC-X Cryocooler, eliminating all non-flight features. The prototype flight coolers will then be subjected to extensive performance and environmental testing with the goal of exiting the program with a cryocooler immediately suitable for an on-orbit flight experiment. Approved for Public Release | 22-MDA-11339 (13 Dec 22)